SOX9 Promotes Breast Cancer Progression via the EGFR/STAT3 Signaling Axis
These findings identify SOX9 as a key regulator of the EGFR/STAT3 signaling pathway in breast cancer. This highlights the potential of SOX9 as both a prognostic biomarker and a promising target for drug therapy in breast cancer.
Authors
- Tipeng Zhang
- Chunrui Zhang (ORCID: https://orcid.org/0000-0002-8170-5509)
- Na Li (ORCID: https://orcid.org/0000-0002-0392-6672)
- Fei Xue (ORCID: https://orcid.org/0000-0001-9914-9582)
Institutions
- Henan Medical University (CN)
Publication Details
- Journal
- Current Cancer Drug Targets
- Published
- 2025-08-22
- DOI
- https://doi.org/10.2174/0115680096369386250717220332
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00